CA2001129A1 - Conjugats de saccharides inhibiteurs des tumeurs - Google Patents

Conjugats de saccharides inhibiteurs des tumeurs

Info

Publication number
CA2001129A1
CA2001129A1 CA2001129A CA2001129A CA2001129A1 CA 2001129 A1 CA2001129 A1 CA 2001129A1 CA 2001129 A CA2001129 A CA 2001129A CA 2001129 A CA2001129 A CA 2001129A CA 2001129 A1 CA2001129 A1 CA 2001129A1
Authority
CA
Canada
Prior art keywords
phosphorus
tumour
sugar
compounds
saccharide conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2001129A
Other languages
English (en)
Other versions
CA2001129C (fr
Inventor
Manfred Wiessler
Michael Dickes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2001129A1 publication Critical patent/CA2001129A1/fr
Application granted granted Critical
Publication of CA2001129C publication Critical patent/CA2001129C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002001129A 1988-10-20 1989-10-20 Conjugats de saccharides inhibiteurs des tumeurs Expired - Lifetime CA2001129C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3835772.0 1988-10-20
DE3835772A DE3835772A1 (de) 1988-10-20 1988-10-20 Tumorhemmende saccharid-konjugate

Publications (2)

Publication Number Publication Date
CA2001129A1 true CA2001129A1 (fr) 1990-04-20
CA2001129C CA2001129C (fr) 2000-06-27

Family

ID=6365559

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002001129A Expired - Lifetime CA2001129C (fr) 1988-10-20 1989-10-20 Conjugats de saccharides inhibiteurs des tumeurs

Country Status (16)

Country Link
US (1) US5622936A (fr)
EP (1) EP0369182B1 (fr)
JP (2) JP2518739B2 (fr)
AT (1) ATE120465T1 (fr)
CA (1) CA2001129C (fr)
DE (2) DE3835772A1 (fr)
DK (1) DK170422B1 (fr)
ES (1) ES2072881T3 (fr)
FI (1) FI95268C (fr)
GR (1) GR3015566T3 (fr)
HK (1) HK157495A (fr)
HU (1) HU206124B (fr)
IE (1) IE67529B1 (fr)
NO (1) NO173548C (fr)
PT (1) PT92034B (fr)
WO (1) WO1990004597A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524515A1 (de) * 1995-07-05 1997-01-09 Deutsches Krebsforsch Saccharid-Konjugate
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
WO2003079980A2 (fr) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Glucuronides, glucosamides et glucosides d'acide carboxylique, de quinolones, penicillines et analogues, et leurs utilisations
WO2003082301A1 (fr) * 2002-03-29 2003-10-09 Threshold Pharmaceuticals, Inc. Compositions et methodes pour le traitement du cancer
CN1771334A (zh) * 2003-03-07 2006-05-10 施瑞修德制药公司 用于确定肿瘤对抗肿瘤药剂的治疗的敏感性的方法
ZA200507752B (en) * 2003-03-28 2007-01-31 Threshold Pharmaceuticals Inc Compositions and methods for treating cancer
US7943586B2 (en) * 2003-06-09 2011-05-17 The Trustees Of The University Of Pennsylvania Antineoplastic agents targeted via glut transporters
NZ549605A (en) * 2004-02-06 2010-01-29 Threshold Pharmaceuticals Inc Use of glufosfamide to treat chemotherapy-refractory pancreatic cancer
EP1883298A1 (fr) * 2005-05-11 2008-02-06 Threshold Pharmaceuticals, Inc. Traitement par une association de glufosfamide
EP1896040B1 (fr) 2005-06-29 2012-08-01 Threshold Pharmaceuticals, Inc. Prodrogues d'alkylateur de phosphoramidate
CN100358910C (zh) * 2006-02-14 2008-01-02 海南天源康泽医药科技有限公司 葡膦酰胺结晶及其制备方法与应用
WO2008011588A2 (fr) * 2006-07-20 2008-01-24 Threshold Pharmaceuticals, Inc. Glycoconjugués d'alkylateurs de phosphoramidate pour le traitement du cancer
ES2884044T3 (es) * 2006-12-26 2021-12-10 Immunogenesis Inc Profármaco alquilante de fosforamidato para el tratamiento del cáncer
US8765690B2 (en) * 2007-04-05 2014-07-01 Threshold Pharmaceuticals, Inc. Treatment of cancer with glufosfamide in patients not receiving insulin therapy
US20090118031A1 (en) * 2007-11-01 2009-05-07 Qualizza Gregory K Shaft Structure with Configurable Bending Profile
CN101481394B (zh) * 2008-01-09 2013-01-30 苏州天人合生物技术有限公司 2,3,4,6-四-o-乙酰基-d-吡喃葡萄糖基-[n, n′-双(2-氯乙基)]-磷酸二酰胺的制备方法
US20110207680A1 (en) * 2008-08-13 2011-08-25 Curd John G Administration of Glufosfamide For The Treatment of Cancer
CN102115483B (zh) 2009-12-30 2014-12-17 苏州天人合生物技术有限公司 卤代双去氧糖衍生物及其制备方法与应用
CN103142626B (zh) * 2010-07-21 2014-08-20 苏州天人合生物技术有限公司 三乙酰葡萄烯糖在制备抗肿瘤药物中的应用
CN105002235B (zh) * 2015-07-10 2019-02-22 江苏九旭药业有限公司 一种利用酶制备葡磷酰胺及其类似物的方法
CN105153251B (zh) * 2015-09-29 2018-03-20 浙江合糖科技有限公司 一种单糖甲苷的苄基化方法
WO2025026214A1 (fr) 2023-07-28 2025-02-06 深圳艾欣达伟医药科技有限公司 Traitement de la mutation du gène p53 ou de patients atteints d'un cancer négatif et d'une tumeur

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122386C (fr) *
DD122386A1 (fr) * 1975-06-24 1976-10-05
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
US5015733A (en) * 1983-12-20 1991-05-14 California Institute Of Technology Nucleosides possessing blocked aliphatic amino groups
US4849513A (en) * 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
US5194428A (en) * 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates

Also Published As

Publication number Publication date
NO173548B (no) 1993-09-20
FI95268B (fi) 1995-09-29
IE67529B1 (en) 1996-04-03
IE893360L (en) 1990-04-20
WO1990004597A1 (fr) 1990-05-03
DK149290D0 (da) 1990-06-19
EP0369182A1 (fr) 1990-05-23
JPH03502934A (ja) 1991-07-04
PT92034B (pt) 1995-05-31
DE3835772A1 (de) 1990-04-26
NO173548C (no) 1993-12-29
DK149290A (da) 1990-08-07
FI903123A0 (fi) 1990-06-20
JP3056408B2 (ja) 2000-06-26
CA2001129C (fr) 2000-06-27
DE58909141D1 (de) 1995-05-04
ES2072881T3 (es) 1995-08-01
HK157495A (en) 1995-10-13
GR3015566T3 (en) 1995-06-30
HUT54702A (en) 1991-03-28
HU206124B (en) 1992-08-28
DK170422B1 (da) 1995-08-28
HU896841D0 (en) 1990-12-28
FI95268C (fi) 1996-01-10
JPH08208680A (ja) 1996-08-13
US5622936A (en) 1997-04-22
ATE120465T1 (de) 1995-04-15
PT92034A (pt) 1990-04-30
NO902717D0 (no) 1990-06-19
JP2518739B2 (ja) 1996-07-31
EP0369182B1 (fr) 1995-03-29
NO902717L (no) 1990-08-20

Similar Documents

Publication Publication Date Title
CA2001129A1 (fr) Conjugats de saccharides inhibiteurs des tumeurs
AU7331094A (en) A3 adenosine receptor agonists
CA2298057A1 (fr) Compositions d'analogue de nucleotide
DK325579A (da) Sukkerderivater af c-076 forbindelser og fremgangsmaade til fremstilling deraf
CA2105112A1 (fr) Procede d'anomerisation de nucleosides
CA2110386A1 (fr) Methode pour la synthezse enzymatique de glycosides oligosaccharidiques alpha-sialyles
AU1880588A (en) Corrosion inhibiting compositions
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
TW349951B (en) Bisconjugates comprising two saccharides and a spacer
BR0013642A (pt) Análogos de nucleosìdeo de pirrolo[2,3-d]pirimidina
ZA964415B (en) Compositions to combat parasitic protozoa
IL54857A (en) Preparation of high frucotse syrups from sucrose by the action of fructosyl transferase
JPS5791998A (en) Novel 5'-o-acylnucleoside derivative and its preparation
NZ186165A (en) Cantilever rack construction connector plate attached to column at roof fillet of column
FI915402A7 (fi) Koostumus ja menetelmä a-D-galaktosidisitoutuneiden tai sitä sisältävi en sokereiden aiheuttamien maha- ja suolistovaivojen vähentämiseksi
ZA911069B (en) Use of alkyl saccharides to enhance the penetration of drugs
EP0321317A3 (en) Device for welding the end of a tubular piece fixed to the inside of a bore hole which opens to a front of a plate, such as a tubular plate of a steam generator
DK576289A (da) Kartonemne indrettet til at fyldes fra enden
WO2003016329A3 (fr) Glycoconjugues de derives d'acide sialique, procedes de production et d'utilisation de ceux-ci
MY103552A (en) Saccharide derivatives
GB2211525B (en) Improvements relating to cog racks or pin-toothed racks
HUT63202A (en) Sacharide preparatives as well as method and device to produce their syntheses
AU519686B2 (en) Corrosion inhibited agricultural compositions
GB8813939D0 (en) Hexafluorophosphates as structure refiner for aluminium-silicon alloys
IT9006709V0 (it) Elemento di collegamento per collegare due componenti costruttivi, preferibilmente per il collegamento frontale di due pannelli

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry